top of page

Xylooligosaccharides (XOS): The Next-Generation Prebiotic for Gut Health

By: Mahak Gupta



Figure 1. Illustration showing the role of xylooligosaccharides (XOS) derived from plant

biomass in modulating the gut microbiome.


Introduction

As research on gut health continues to evolve, prebiotics have emerged as key dietary

components that support a balanced microbiome. While traditional prebiotics such as inulin and fructooligosaccharides (FOS) are widely studied, a new class of compounds-

xylooligosaccharides (XOS) is gaining attention for its potent and efficient effects on gut health (1,2). Derived from plant-based materials, XOS represents a promising bridge between sustainable food production and advanced nutritional science.


What Are Xylooligosaccharides (XOS)?

Xylooligosaccharides (XOS) are short-chain sugar polymers composed of xylose units, typically obtained from the breakdown of xylan, a major component of hemicellulose in plant cell walls (3).


They are naturally present in fruits, vegetables, bamboo shoots, and honey, and can also be

produced from agricultural residues such as corn cobs, wheat straw, and sugarcane bagasse (3). Unlike many dietary components, XOS are resistant to digestion in the upper gastrointestinal tract, allowing them to reach the colon intact where they exert their prebiotic effects (1).


How XOS Works in the Gut

Once in the colon, XOS is selectively fermented by beneficial bacteria such as Bifidobacterium and Lactobacillus (2,4). This selective fermentation is what makes XOS particularly effective. Compared to traditional prebiotics, XOS works at much lower doses and shows high selectivity for beneficial microbes, leading to rapid production of short-chain fatty acids (SCFAs) (2,5). These SCFAs play key roles in improving gut barrier integrity, reducing inflammation, and supporting immune function (5,6).


Why XOS Is Considered “Next-Generation”

XOS stands out from conventional prebiotics for several reasons. It demonstrates high efficiency even at low concentrations and remains stable under heat, pH variations, and food processing conditions (2). Additionally, XOS promotes selective growth of beneficial bacteria while suppressing harmful microbial populations, contributing to improved gut health (4,5).


From Biomass to Prebiotics: A Sustainable Advantage

One of the most significant advantages of XOS is its sustainable production from lignocellulosic biomass, including agricultural residues such as sugarcane bagasse, barley straw, and corn husk (7,8). These materials are rich in hemicellulose, particularly xylan, which can be converted into XOS through chemical and enzymatic processes (3).

This approach not only reduces agricultural waste but also contributes to the development of a circular bioeconomy by transforming low-value biomass into high-value functional food

ingredients (7,8).


Health Benefits of XOS

Research indicates that XOS provides multiple health benefits, including improved gut

microbiota balance, enhanced immune response, and reduced gastrointestinal disorders (4,6). XOS has also been associated with improved mineral absorption and metabolic regulation, making it a promising dietary component for long-term health (5,6). Emerging evidence suggests potential roles in weight management and reduction of inflammation (6).


Applications in Functional Foods

Due to its stability and effectiveness, XOS is increasingly being incorporated into functional

foods such as dairy products, baked goods, beverages, and dietary supplements (2). It is

particularly valuable in the development of synbiotic formulations, where it enhances the

survival and activity of probiotic strains (4).


Future Perspectives

With growing interest in microbiome-based therapies and personalized nutrition, XOS is

expected to play a significant role in next-generation dietary strategies (9). Future research is

focusing on optimizing production processes, understanding microbiome interactions, and

expanding applications in functional food systems (9,10).


Conclusion

Xylooligosaccharides (XOS) represents a powerful advancement in prebiotic science. Combining efficiency, stability, and sustainability, it stands out as a next-generation solution for improving gut health. As microbiome research continues to expand, XOS is likely to become a key component in both clinical nutrition and functional food innovation (9,10).


References

1. Gibson GR, Hutkins R, Sanders ME, et al. The International Scientific Association for

Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of

prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502.

2. Aachary AA, Prapulla SG. Xylooligosaccharides (XOS) as an emerging prebiotic:

microbial synthesis, utilization, structural characterization, bioactive properties, and

applications. Compr Rev Food Sci Food Saf. 2011;10(1):2–16.

3. Zhang J, Viikari L. Xylooligosaccharides production from lignocellulosic biomass. Appl

Microbiol Biotechnol. 2018; 102:9081–9088.

4. Markowiak P, Śliżewska K. Effects of probiotics, prebiotics, and synbiotics on human

health. Nutrients. 2017;9(9):1021.

5. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut

Microbes. 2017;8(2):172–184.

6. Verbeke KA, Boobis AR, Chiodini A, et al. Towards microbial fermentation metabolites

as markers for health benefits of prebiotics. Nutr Res Rev. 2015;28(1):42–66.

7. Liu CG, Xiao Y, Xia XX, et al. Cellulosic ethanol production: progress, challenges and

strategies for solutions. Biotechnol Adv. 2018;36(3):681–698.

8. Gupta M. Prebiotic production from lignocellulosic materials and their application for

development of cereal-based synbiotic foods. PhD Thesis. University of Jammu; 2019.

9. Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities

for therapy. J Clin Invest. 2025;135(4): e184323.

10. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and

health. Nat Rev Microbiol. 2024; 22:123–138.


Assessed and Endorsed by the MedReport Medical Review Board

 
 

©2025 by The MedReport Foundation, a Washington state non-profit organization operating under the UBI 605-019-306

 

​​The information provided by the MedReport Foundation is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. The MedReport Foundation's resources are solely for informational, educational, and entertainment purposes. Always seek professional care from a licensed provider for any emergency or medical condition. 
 

bottom of page